Toxoplasmosis in Cats: Zoonotic Risk and Public Health Implications

Introduction

Toxoplasmosis is a globally distributed zoonotic disease caused by the obligate intracellular protozoan parasite Toxoplasma gondii. Felids, including domestic cats, serve as the definitive host in which the parasite completes its sexual cycle and produces environmentally resistant oocysts [1, 2]. The parasite infects a broad range of warm-blooded intermediate hosts, including humans, livestock, and wildlife [3, 4, 5]. This article provides an exhaustive review of feline toxoplasmosis with emphasis on the zoonotic risk posed by infected cats and the public health implications of environmental contamination with T. gondii oocysts. The discussion integrates recent molecular, epidemiological, and diagnostic advances while adhering to a strictly veterinary and comparative biology perspective.

Etiology and Life Cycle

Toxoplasma gondii is a member of the phylum Apicomplexa. The life cycle is heteroxenous, with sexual reproduction occurring exclusively in the intestinal epithelium of felids [1, 2]. A single-cell atlas of sexual development in the feline intestinal tract has provided high-resolution transcriptomic maps of the transition from asexual to sexual stages, including the formation of macrogametes and microgametes [2]. Proliferating pre-sexual stages exhibit characteristic cell division patterns that prime the parasite for gametogenesis [1].

After ingestion of tissue cysts (containing bradyzoites) from infected intermediate hosts, bradyzoites are released in the feline small intestine, invade enterocytes, and undergo multiple rounds of schizogony [6]. The dynamic landscape of microRNA expression in the feline small intestine during infection modulates host cell pathways to support parasitic replication [6]. Gametogony follows, producing oocysts that are shed in feces. Oocysts sporulate in the environment within 1 to 5 days and become infective to intermediate hosts [7, 8].

Three infectious stages exist: sporozoites (within sporulated oocysts), tachyzoites (rapidly dividing form during acute infection), and bradyzoites (slowly dividing form within tissue cysts). Cats can also acquire infection by ingesting sporulated oocysts, leading to a shorter prepatent period and lower magnitude of oocyst shedding [8].

Epidemiology

Seroprevalence in Cats

The seroprevalence of anti-T. gondii antibodies in domestic cats varies widely by geographic region, management practices, and age. In Hong Kong, seroprevalence in privately owned cats was 11.2% while community cats showed 24.7% positivity, with outdoor access and raw meat consumption identified as significant risk factors [9]. In Jordan, seroprevalence in cats reached 29.8%, and molecular detection in feces confirmed active shedding in a subset of seronegative individuals [8]. In urban informal settlements in Salvador, Brazil, seroprevalence among companion animals, including cats, was elevated in areas with poor sanitation and high rodent density [10]. Similarly, social marginalization and environmental degradation were associated with higher T. gondii exposure in Brazilian informal settlements [11].

Risk Factors

Risk factors for feline seropositivity include free-roaming lifestyle, hunting behavior, consumption of raw or undercooked meat, and high rodent density [9, 8, 10]. Stray cats in Bangkok, Thailand, demonstrated a 17.8% oocyst shedding rate by PCR, indicating ongoing environmental contamination [7]. In Brazil, high seroprevalence rates were also observed in dogs from the Pantanal region, underscoring the ecological spillover from infected definitive hosts [4].

Zoonotic Transmission Pathways

Humans acquire T. gondii primarily through ingestion of sporulated oocysts from contaminated soil, water, or produce, and through consumption of undercooked meat containing tissue cysts from intermediate hosts such as pigs, sheep, goats, and cattle [3, 5, 12]. Feline feces are the sole source of oocysts, making cat ownership a putative risk factor for human infection, particularly in pregnant women and immunocompromised individuals [13]. However, the relative contribution of cat exposure versus foodborne transmission remains debated [14, 13]. In a study from Côte d'Ivoire, pregnant women demonstrated poor knowledge of toxoplasmosis prevention, including handling of cat litter [14].

Clinical Signs in Cats

Most immunocompetent cats infected with T. gondii remain asymptomatic. Clinical disease occurs more frequently in kittens, immunosuppressed cats, or those co-infected with other pathogens. Common manifestations include fever, lethargy, anorexia, and lymphadenopathy. Ocular toxoplasmosis presents as uveitis, chorioretinitis, or anterior chamber inflammation [15]. Neurological signs (ataxia, seizures, cranial nerve deficits) arise from meningoencephalitis caused by tachyzoite proliferation in the central nervous system. Respiratory signs (dyspnea, coughing) result from interstitial pneumonia. Hepatic and pancreatic involvement cause icterus and vomiting. Myocarditis may lead to arrhythmias and sudden death.

Pathology

Gross pathological findings in acute feline toxoplasmosis include multifocal necrotic foci in liver, lung, pancreas, and brain. Histologically, tachyzoites and tissue cysts are observed within inflammatory lesions. Immunohistochemical staining using antibodies against T. gondii antigens (e.g., SAG1, MIC17A) facilitates detection in tissue sections [16]. MIC17A has been identified as a potential entero-epithelial and chronic stage marker for diagnosis in cats [16].

Diagnostics

A combination of serological, molecular, and antigen detection methods is used for diagnosis. Commercial ELISA kits and indirect immunofluorescence assays detect anti-T. gondii IgG and IgM antibodies [17, 18, 16]. The double-antigen sandwich colloidal gold immunochromatographic strip (ICS) has been developed for multispecies antibody detection, including cats, offering rapid point-of-care testing [17]. A SAG1-based colloidal gold ICS specifically for swine also shows cross-reactivity potential for feline samples [18].

Molecular assays targeting the B1 gene or 529 bp repeat element provide high sensitivity and specificity. An antisense PCR assay designed to detect T. gondii DNA in feline blood and feces demonstrated improved sensitivity compared to conventional PCR [19]. Detection of oocysts in feces is achieved by microscopy (e.g., Sheather's sugar flotation) followed by PCR confirmation, though PCR from fecal samples can be challenging due to inhibitors [7, 19].

graph TD
    A[Cat with suspected toxoplasmosis], > B{Clinical signs?}
    B, >|Ocular/neurologic/systemic| C[Serum antibody testing]
    B, >|Asymptomatic but risk assessment| D[History of hunting/raw diet]
    C, > E{IgG positive, IgM negative?}
    E, >|Yes| F[Chronic infection, unlikely shedding]
    E, >|No – IgM positive or rising IgG| G[Acute infection – consider molecular testing]
    D, > H[Fecal PCR for oocyst DNA]
    G, > I[Blood PCR]
    H, > J[Result positive: active shedding; implement hygiene]
    I, > K[Result positive: active systemic infection; consider treatment]
    J, > L[Repeat fecal test in 2-4 weeks to monitor shedding]
    K, > M[Clinical management with antiprotozoal therapy]

Treatment

Treatment is indicated for cats with clinical toxoplasmosis. Clindamycin is the first-line antiprotozoal, administered at 10 to 12 mg/kg orally every 12 hours for 2 to 4 weeks. Alternative therapies include trimethoprim-sulfonamide combinations, azithromycin, and pyrimethamine combined with sulfadiazine. Supportive care (fluid therapy, nutritional support, and anti-inflammatory doses of corticosteroids for ocular inflammation) is often necessary.

Control of oocyst shedding in acutely infected cats may be achieved by administration of clindamycin or ponazuril (toltrazuril sulfone) to reduce the magnitude and duration of shedding. However, no drug completely eliminates the entero-epithelial stages, and reinfection can occur.

Zoonotic Risk and Public Health Implications

Cat Toxoplasmosis Baby

The concern regarding "cat toxoplasmosis baby" refers to the risk of congenital toxoplasmosis when a pregnant woman acquires a primary infection. Oocysts from cat feces can contaminate the hands of cat owners during litter box cleaning or through contact with contaminated soil [13]. Primary infection during pregnancy can lead to transplacental transmission, causing fetal death, chorioretinitis, intracranial calcifications, and hydrocephalus in the neonate [20, 21]. In Kars, Turkey, women with abortion or stillbirth history showed significantly higher anti-T. gondii seropositivity compared to controls [20]. In Brazil, seropositivity in women with sickle cell disease was associated with blood transfusion history, but the role of cat ownership was not independently assessed [21]. Quilombola communities in Brazil exhibited high prevalence of ocular toxoplasmosis, with environmental exposure likely driven by cat presence and soil contact [22].

Pregnant women who are seronegative should avoid handling cat litter or wear gloves and wash hands thoroughly thereafter [13]. Cats that are kept strictly indoors and fed commercial cooked food pose minimal risk of shedding oocysts [13].

Immunocompromised Hosts

Toxoplasmosis in immunocompromised individuals, including organ transplant recipients and those with HIV/AIDS, can result in severe reactivation with encephalitis, myocarditis, or pneumonitis [23]. Cerebral toxoplasmosis has been described in renal transplant recipients as a rare but life-threatening complication [23]. Veterinary professionals and students, who have frequent occupational exposure to cats, show seroprevalence rates comparable to the general population but may benefit from heightened awareness and protective measures [24].

Public Health Burden

The public health burden of toxoplasmosis is substantial. Human seroprevalence in many regions remains high, and chronic infection has been associated with neuropsychiatric effects, including psychotic experiences and reduced grey matter volume in population-based cohort studies [25]. Parasitic manipulation of host behavior has been documented in intermediate hosts, though the significance for human behavior remains under investigation [26].

One Health Perspective and Control Strategies

A One Health approach integrating veterinary and human medical surveillance is essential for reducing the zoonotic risk. Educational interventions targeting cat owners, pregnant women, and veterinarians improve knowledge and preventive practices [24, 14, 27]. University students in Erbil, Iraq demonstrated low awareness of toxoplasmosis transmission routes, indicating a need for public health campaigns [27].

Vaccine development offers long-term hope for reducing oocyst shedding in cats and preventing infection in intermediate hosts. Gene-edited live-attenuated vaccines have shown promise in eliciting protective immune responses [28]. Advances in antigen discovery, including mRNA vaccine platforms, are being explored under One Health strategies [29]. However, licensed vaccines for cats are not yet commercially available.

Environmental control includes preventing cat access to livestock feed and water sources, implementing rodent control, and proper disposal of cat feces. Farmers and veterinarians in endemic areas should monitor infection in sentinel species such as goats, sheep, and pigs [3, 30, 12].

References

[1] Sena F, Hakimi M-A, Francia ME. Proliferating toward sex: characterization of cell division of Toxoplasma gondii's pre-sexual stages. mBio. 2026. https://pubmed.ncbi.nlm.nih.gov/42153709/

[2] Alrubaye HS, Reilly SM, da Silva R, et al. A single-cell atlas of Toxoplasma sexual development in the feline intestinal tract. Nat Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42020723/

[3] Muhammad AS, Kudi AC, Mohammed A, et al. Public health significance of prevalence and risk factors associated with Toxoplasma gondii infection in goats sampled from two quarantine facilities and an institutional farm in Maiduguri metropolis, Borno state, Nigeria. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/42020619/

[4] Artiaga-Silva GL, de Lima Ruy Dias ÁF, Carvalho MR, et al. High Seroprevalence Rates of Toxoplasma gondii and Neospora caninum in Dogs in the Pantanal Region of Mato Grosso, Brazil. Acta Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41843222/

[5] Hanedan B, Taş BZ, Yıldırım E, et al. Investigation of Toxoplasma gondii seroprevalence and associated risk factors in dairy cattle in the Eastern Anatolia region of Türkiye. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41819961/

[6] Zhai B, Bao B, Xie SC, et al. Dynamic landscape of microRNA expression in the feline small intestine during Toxoplasma gondii infection. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/41965856/

[7] Kengradomkij C, Chimnoi W, Kamyingkird K, et al. PCR detection of Toxoplasma gondii DNA in fecal samples from stray cats in Bangkok Metropolitan, Thailand. Food Waterborne Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42094705/

[8] Alkhatatbeh SK, Lafi SQ, Hammad HB, et al. The first seroprevalence and molecular detection of toxoplasmosis infecting cats in Jordan with associated risk factors. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741047/

[9] Elsohaby I, Zubair M, Baqar Z, et al. Seroprevalence of Toxoplasma gondii and associated demographic factors in privately-owned dogs, cats, and community cats in Hong Kong. BMC Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42135800/

[10] Bazan L, Argibay HD, Borges-Silva W, et al. Seroprevalence and risk factors for Toxoplasma gondii infection in wild, domestic and companion animals in urban informal settlements from Salvador, Brazil. PLoS Negl Trop Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/41401226/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[11] Eyre MT, Wang JY, Carneiro IO, et al. Social marginalisation, environmental degradation and Toxoplasma gondii exposure in urban informal settlements in Brazil. PLoS Negl Trop Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42330015/

[12] Marín-García PJ, Ballesteros-García O, Martínez-Sáez L, et al. Low seroprevalence of Toxoplasma gondii in pig farms (Sus scrofa domesticus) of eastern Spain in intensive farms with control of animal entry. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41741032/

[13] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. https://pubmed.ncbi.nlm.nih.gov/41628830/

[14] Henriette BA, Jémima EK, Jean-Sébastien MA, et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42199683/

[15] Askaryanzardak A, Kakkassery V, Tartaglione Gracia GP, et al. [Ocular toxoplasmosis in adults : Refresher course]. Ophthalmologie. 2026. https://pubmed.ncbi.nlm.nih.gov/41603939/

[16] Günay-Esiyok Ö, Koçkaya ES, Yılmaz R, et al. The Potential of MIC17A both as an Entero-epithelial and Chronic Stage Marker for Detection of Feline Toxoplasmosis. Curr Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41874672/

[17] Mu X, Chen C, Pu X, et al. Development and Field Validation of a Double-Antigen Sandwich Colloidal Gold Immunochromatographic Strip for Detection of Toxoplasma gondii Antibodies in Multiple Host Species. Transbound Emerg Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42253330/

[18] Chen XX, Sun H, Liang Y, et al. Development of a SAG1-based colloidal gold immunochromatographic strip for rapid serological detection of swine Toxoplasma gondii. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42169035/

[19] Li YY, Bai SY, Yu HQ, et al. Development and evaluation of an antisense PCR assay for Toxoplasma gondii detection in domestic cats. Vet Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/41724116/

[20] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. https://pubmed.ncbi.nlm.nih.gov/42202767/

[21] Orish VN, Tetteh RE, Adzah D, et al. Toxoplasma gondii seropositivity among patients with sickle cell disease: Prevalence and association with blood transfusion history. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41931585/

[22] Filho SCC, Moron SE, Ferreira RG, et al. Risk Factors and Ocular Health Associated with Toxoplasmosis in Quilombola Communities. Microorganisms. 2026. https://pubmed.ncbi.nlm.nih.gov/41597614/

[23] Mihaljević D, Sitaš Z, Hanulak J, et al. Cerebral Toxoplasmosis in a Renal Transplant Recipient-A Rare Complication. Life (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/41900989/

[24] de Velasco-Reyes I, Torres-García SE, Hernández-Rangel JJ, et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/42201205/

[25] Jesuthasan J, Merritt K, Solmi F, et al. The association between childhood Toxoplasma gondii, psychotic experiences and grey matter volume: A population-based cohort study. Schizophr Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41643571/

[26] Loeb J. Thrill seekers: how parasites change host behaviour. Vet Rec. 2026. https://pubmed.ncbi.nlm.nih.gov/41481062/

[27] Chalabi KN, Jabar Bakr E. Toxoplasmosis - knowledge among university students in Erbil, Iraq: a cross-sectional study. Int J Environ Health Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41873025/

[28] Sang X, Zhang H, Zhang Y, et al. Gene-edited live-attenuated vaccines against Toxoplasma gondii: recent advances and future frontiers. Parasit Vectors. 2026. https://pubmed.ncbi.nlm.nih.gov/42252477/

[29] Qadeer A, Tharwat M, Khan MZ, et al. Advances and Translational Challenges in Toxoplasma gondii Vaccine Development: From Antigen Discovery to mRNA and One Health Strategies. Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42188907/

[30] Ait Issad N, Mohamed Cherif A, Mebkhout F, et al. First report of molecular and histopathological detection of Toxoplasma gondii in aborted fetal goat myocardium in Algeria with associated risk factors. Parasitol Int. 2026. https://pubmed.ncbi.nlm.nih.gov/41864556/

[31] Pinto GOA, Silva RAD, Oliveira PRF, et al. Molecular detection of Toxoplasma gondii in an aborted equine fetus and serological evidence of infection in mares enrolled in embryo transfer programs in Brazil. J Equine Vet Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42252005/

[32] Aziz KJ, Mikaeelb FB, Nasrullah OJ, et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/42034957/

[33] Murata FHA, Barboza JP, de Souza CAG, et al. Investigation of Toxoplasma gondii in reproductive tissues of companion animals from a municipal neutering program. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41651631/

[34] Biswas PK, Aryal D, Tarak AN, et al. Genotype distribution and risk factors of Toxoplasma gondii infection in animals of Trishal, Bangladesh. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/41528989/

[35] Spada E, Tattarletti G, Proverbio D, et al. The AB Blood Group System Phenotype Does Not Play a Role in Toxoplasma gondii Infection in Cats. Pathogens. 2025. https://pubmed.ncbi.nlm.nih.gov/41471183/